This issue of Heart Failure Clinics, edited by Drs. Ragavendra R. Baliga and Umesh C. Samal, will focus on Recent Advances in Management of Heart Failure. Topics include, but are not limited to, Neprilysin Inhibition on Systolic HF, If Channel Inhibitor Ivabradine in Heart Failure, Growth Hormone Therapy in Heart Failure, Ultrafiltration in Heart Failure, Aldosterone Receptor Blockade in Diastolic HF, Intravenous Iron Therapy in HF, Management of Secondary Pulmonary Hypertension, Management of Chemotherapy Induced Cardiomyopathy, Management of HF in Adult Congenital Heart Disease, LVADS in Heart Failure, Short Term Circulatory & Right Ventricle support in Cardiogenic Shock, Mitral Valve Repair in HF, Total Artificial Heart, Current Status of Inotropes in Heart Failure, Palliative Therapy in Heart Failure, Subcutaneous ICDs and Leadless Pacemakers, Interventional Heart Failure and Hemodynamic Monitoring, and Management of Sleep Apnea in Heart Failure.

This issue of Heart Failure Clinics, edited by Drs. Ragavendra R. Baliga and Umesh C. Samal, will focus on Recent Advances in Management of Heart Failure. Topics include, but are not limited to, Neprilysin Inhibition on Systolic HF, If Channel Inhibitor Ivabradine in Heart Failure, Growth Hormone Therapy in Heart Failure, Ultrafiltration in Heart Failure, Aldosterone Receptor Blockade in Diastolic HF, Intravenous Iron Therapy in HF, Management of Secondary Pulmonary Hypertension, Management of Chemotherapy Induced Cardiomyopathy, Management of HF in Adult Congenital Heart Disease, LVADS in Heart Failure, Short Term Circulatory & Right Ventricle support in Cardiogenic Shock, Mitral Valve Repair in HF, Total Artificial Heart, Current Status of Inotropes in Heart Failure, Palliative Therapy in Heart Failure, Subcutaneous ICDs and Leadless Pacemakers, Interventional Heart Failure and Hemodynamic Monitoring, and Management of Sleep Apnea in Heart Failure.

This issue of Heart Failure Clinics, edited by Drs. Ragavendra R. Baliga and Umesh C. Samal, will focus on Recent Advances in Management of Heart Failure. Topics include, but are not limited to, Neprilysin Inhibition on Systolic HF, If Channel Inhibitor Ivabradine in Heart Failure, Growth Hormone Therapy in Heart Failure, Ultrafiltration in Heart Failure, Aldosterone Receptor Blockade in Diastolic HF, Intravenous Iron Therapy in HF, Management of Secondary Pulmonary Hypertension, Management of Chemotherapy Induced Cardiomyopathy, Management of HF in Adult Congenital Heart Disease, LVADS in Heart Failure, Short Term Circulatory & Right Ventricle support in Cardiogenic Shock, Mitral Valve Repair in HF, Total Artificial Heart, Current Status of Inotropes in Heart Failure, Palliative Therapy in Heart Failure, Subcutaneous ICDs and Leadless Pacemakers, Interventional Heart Failure and Hemodynamic Monitoring, and Management of Sleep Apnea in Heart Failure.